Effects of GPR139 agonism on effort expenditure for food reward in rodent models: Evidence for pro-motivational actions.
Apathy
GPR139
Operant behavior
Reward-to-effort valuation
Rodent
Stress
TAK-041
Journal
Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217
Informations de publication
Date de publication:
01 08 2022
01 08 2022
Historique:
received:
16
11
2021
revised:
02
05
2022
accepted:
04
05
2022
pubmed:
14
5
2022
medline:
7
6
2022
entrez:
13
5
2022
Statut:
ppublish
Résumé
Apathy, deficiency of motivation including willingness to exert effort for reward, is a common symptom in many psychiatric and neurological disorders, including depression and schizophrenia. Despite improved understanding of the neurocircuitry and neurochemistry underlying normal and deficient motivation, there is still no approved pharmacological treatment for such a deficiency. GPR139 is an orphan G protein-coupled receptor expressed in brain regions which contribute to the neural circuitry that controls motivation including effortful responding for reward, typically sweet gustatory reward. The GPR139 agonist TAK-041 is currently under development for treatment of negative symptoms in schizophrenia which include apathy. To date, however, there are no published preclinical data regarding its potential effect on reward motivation or deficiencies thereof. Here we report in vitro evidence confirming that TAK-041 increases intracellular Ca
Identifiants
pubmed: 35561791
pii: S0028-3908(22)00137-X
doi: 10.1016/j.neuropharm.2022.109078
pii:
doi:
Substances chimiques
Gpr139 protein, mouse
0
Nerve Tissue Proteins
0
Receptors, G-Protein-Coupled
0
Dopamine
VTD58H1Z2X
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
109078Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.